These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15327399

  • 1. Recombinant uteroglobin prevents the experimental crescentic glomerulonephritis.
    Lee DS, Yang SH, Kim HL, Joo KW, Lim CS, Chae DW, Kim S, Lee JS, Kim YS.
    Kidney Int; 2004 Sep; 66(3):1061-7. PubMed ID: 15327399
    [Abstract] [Full Text] [Related]

  • 2. The protective role of uteroglobin through the modulation of tissue transglutaminase in the experimental crescentic glomerulonephritis.
    Yang SH, Shin SJ, Oh JE, Jin JZ, Chung NH, Lim CS, Kim S, Kim YS.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3437-45. PubMed ID: 18558621
    [Abstract] [Full Text] [Related]

  • 3. [The roles of T cells in experimental crescentic glomerulonephritis].
    Zhou KX, Zou WZ.
    Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):100-2. PubMed ID: 1499070
    [Abstract] [Full Text] [Related]

  • 4. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
    Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR.
    Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
    [Abstract] [Full Text] [Related]

  • 5. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK, Kitching AR, Jones LK, Holdsworth SR.
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [Abstract] [Full Text] [Related]

  • 6. Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis.
    Saga D, Sakatsume M, Ogawa A, Tsubata Y, Kaneko Y, Kuroda T, Sato F, Ajiro J, Kondo D, Miida T, Narita I, Gejyo F.
    Kidney Int; 2005 May; 67(5):1821-9. PubMed ID: 15840029
    [Abstract] [Full Text] [Related]

  • 7. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
    Le Hir M, Haas C, Marino M, Ryffel B.
    Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
    [Abstract] [Full Text] [Related]

  • 8. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM.
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [Abstract] [Full Text] [Related]

  • 9. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D, Nazneen A, Taguchi T, Razzaque MS.
    Am J Nephrol; 2008 Oct; 28(4):555-68. PubMed ID: 18239382
    [Abstract] [Full Text] [Related]

  • 10. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
    Terada Y, Okado T, Inoshita S, Hanada S, Kuwahara M, Sasaki S, Yamamoto T, Marumo F.
    Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941
    [Abstract] [Full Text] [Related]

  • 11. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM, Ng YY, Lin SL, Chiang WC, Lan HY, Tsai TJ.
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [Abstract] [Full Text] [Related]

  • 12. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
    Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR.
    Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N.
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [Abstract] [Full Text] [Related]

  • 14. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB, Cook HT, Bhangal G, Smith J, Tam FW, Pusey CD.
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [Abstract] [Full Text] [Related]

  • 15. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
    Zhao M, Ding J, Liu Y, Zou W, Wang H.
    Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
    [Abstract] [Full Text] [Related]

  • 16. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M, Fujinaka H, Adhikary LP, Kovalenko P, El-Shemi AG, Yoshida Y, Yaoita E, Takeishi T, Takeya M, Naito M, Suzuki H, Yamamoto T.
    Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
    [Abstract] [Full Text] [Related]

  • 17. Platelets are not critical effector cells for the time course of murine passive crescentic glomerulonephritis.
    Hohenstein B, Daniel C, Johnson RJ, Amann KU, Hugo CP.
    Platelets; 2013 Dec; 24(4):267-74. PubMed ID: 22779773
    [Abstract] [Full Text] [Related]

  • 18. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury.
    Boyce NW, Holdsworth SR.
    J Immunol; 1985 Dec; 135(6):3918-21. PubMed ID: 4067309
    [Abstract] [Full Text] [Related]

  • 19. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation.
    Ikezumi Y, Hurst LA, Masaki T, Atkins RC, Nikolic-Paterson DJ.
    Kidney Int; 2003 Jan; 63(1):83-95. PubMed ID: 12472771
    [Abstract] [Full Text] [Related]

  • 20. Correlation between T cells and experimental crescentic glomerulonephritis.
    Zou WZ, Zhou KX.
    Chin Med J (Engl); 1990 Oct; 103(10):805-10. PubMed ID: 2125253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.